Lv1
30 积分 2024-05-22 加入
Molecular imaging supports the development of multispecific cancer antibodies
1个月前
已完结
Dual HER2 inhibition: mechanisms of synergy, patient selection, and resistance
1个月前
已完结
Controlled Fab-arm exchange for the generation of stable bispecific IgG1
1个月前
已完结
New promises and challenges in the treatment of advanced non-small-cell lung cancer
2个月前
已完结
Therapeutic potential of cis-targeting bispecific antibodies
3个月前
已完结
IgG-VHH bispecific fusion antibodies: challenges and opportunities as therapeutic agents
3个月前
已完结
Phase II trial of HER-Vaxx, a B cell peptide-based vaccine, in HER2-overexpressing advanced gastric cancer patients under platinum-based chemotherapy (HERIZON)
3个月前
已完结
A randomized phase 2 study of HLX22 plus trastuzumab biosimilar HLX02 and XELOX as first-line therapy for HER2-positive advanced gastric cancer
3个月前
已完结
HER2-targeted therapies beyond breast cancer — an update
3个月前
已完结
Efficacy of administration sequence: Sacituzumab Govitecan and Trastuzumab Deruxtecan in HER2-low metastatic breast cancer
4个月前
已完结
皖公网安备34019202002308
